Exploring Tualang Honey formulation and Synvisc in rabbit osteoarthritis
INTRODUCTION: Tualang Honey, characterised by its anti-inflammatory and antioxidative properties, presents a novel therapeutic approach to osteoarthritis (OA) management. This study evaluates the efficacy of a Tualang Honey Formulation (THF) (Patent no. MY179303-A) injection, compared to Synvisc,...
Saved in:
Main Authors: | Abd Rahim, Nour El Huda, Mohamad Amri, Nur Fathonah, Zulkifly, Ahmad Hafiz, Hassan, Habibah, Mohd Jan, Nurul Hafiza, Ibrahim, Mohd Zulfadzli |
---|---|
Format: | Article |
Language: | English |
Published: |
Malaysian Orthopaedic Association (MOA)
2024
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/116541/1/116541_Exploring%20Tualang%20Honey%20formulation.pdf http://irep.iium.edu.my/116541/ https://www.morthoj.org/supplements/moa-2024/index.php |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of Tualang honey formulation in osteoarthritis: a comparative study in New Zealand white rabbit models
by: Mohamad Amri, Nur Fathonah, et al.
Published: (2024) -
Treatment of osteoarthritis using Synvisc in New Zealand white rabbit
by: Abdul Hamid, Zahana, et al.
Published: (2023) -
Treatment of osteoarthritis using Synvisc in New Zealand white rabbit
by: Abdul Hamid, Zahana, et al.
Published: (2023) -
Tualang honey formulation as potential osteoarthritis treatment: in-vitro cytotoxicity outcome
by: Zulkifly, Ahmad Hafiz, et al.
Published: (2024) -
Tualang Honey formulation as potential osteoarthritis treatment: in-vitro genotoxicity outcome
by: Abd Rahim, Nour El Huda, et al.
Published: (2024)